Journal
TRENDS IN BIOTECHNOLOGY
Volume 19, Issue 7, Pages 255-265Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/S0167-7799(01)01665-1
Keywords
-
Categories
Ask authors/readers for more resources
The advent of bone growth factors has been widely anticipated since their successful production using recombinant DNA technology. Bone morphogenetic proteins (BMPs) are an im porta nt class of bone growth factors and will be the focus of this article. In the near future these therapeutics might revolutionize how clinicians treat such diverse orthopedic applications as the healing of broken bones, increasing bone density lost th rough aging, and strengthening the spine. These potent proteins require application directly at the site of repair via a delivery system, The choice of delivery system has a profound effect on the clinical outcome. In the past decade, researchers have focused on developing efficient delivery systems and advancing these factors from the bench to the clinic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available